Torrent Pharmaceuticals reported a 30% year-on-year rise in Q2 profit to ₹591 crore, driven by strong growth across its India and US markets, while revenue climbed 14% to ₹3,302 crore.
Read Full
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
